Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 42.79B | 49.60B | 35.41B | 28.98B | 29.76B |
Gross Profit | 8.26B | 9.41B | 8.05B | 6.93B | 6.22B |
EBITDA | 5.50B | 6.67B | 5.18B | 4.32B | 3.54B |
Net Income | 2.38B | 3.23B | 2.54B | 2.00B | 1.38B |
Balance Sheet | |||||
Total Assets | 44.32B | 47.55B | 41.92B | 36.93B | 37.56B |
Cash, Cash Equivalents and Short-Term Investments | 3.40B | 4.94B | 3.54B | 3.41B | 4.74B |
Total Debt | 8.91B | 12.17B | 11.14B | 10.13B | 11.59B |
Total Liabilities | 20.06B | 24.30B | 21.62B | 19.21B | 21.81B |
Stockholders Equity | 24.97B | 23.13B | 20.21B | 17.65B | 15.70B |
Cash Flow | |||||
Free Cash Flow | 3.99B | 1.12B | -434.00M | 625.00M | 1.25B |
Operating Cash Flow | 4.97B | 2.04B | 2.00B | 2.37B | 2.96B |
Investing Cash Flow | -1.89B | -961.00M | -2.32B | -1.86B | -1.41B |
Financing Cash Flow | -4.74B | 245.00M | 308.00M | -1.82B | -2.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | €659.15B | 15.45 | 18.55% | 3.53% | 10.88% | 14.80% | |
78 Outperform | ¥189.29B | 12.44 | 2.34% | 0.50% | -8.77% | ||
77 Outperform | ¥264.87B | 15.00 | 6.33% | 4.42% | 61.92% | ||
74 Outperform | $729.81B | 12.59 | 7.04% | 4.08% | 5.74% | 1.14% | |
71 Outperform | ¥184.85B | 11.23 | 6.29% | 3.20% | 3.88% | 3.23% | |
64 Neutral | ¥33.84B | 10.70 | 2.81% | 9.33% | 45.97% | ||
54 Neutral | ¥181.95B | 15.29 | -4.17% | 4.74% | 2.82% | -202.98% |